Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-11-15

FDA Approved: MOEXIPRIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Moexipril Hydrochloride by Teva Pharmaceuticals USA, Inc. Moexipril Hydrochloride is an ACE inhibitor used to treat …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moexipril hydrochloride (Moexipril hydrochloride)

Snippet

SUPPL AP for MOEXIPRIL HYDROCHLORIDE (MOEXIPRIL HYDROCHLORIDE)